For 2 cents extra... I think the game is that they get access to do some more due diligence and then can come back with a more palatable offer of 80 cents+ that shareholders will accept.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025